EMT and Cancer: More Than Meets the Eye

Overview

Journal Dev Cell

Publisher Cell Press

Specialties Cell Biology
Reproductive Medicine

Date 2019 May 8

PMID 31063750

Citations 167

Authors

Rik Derynck

Robert A Weinberg

Affiliations

Soon will be listed here.

Abstract

Epithelial cells acquire mesenchymal characteristics during development, wound healing and inflammation, and in cancer and fibrosis. With increasing appreciation of different roles of epithelial-mesenchymal transition (EMT), we address the question of how to define and recognize EMT processes and discuss their properties in cancer progression.

Citing Articles

A Multicellular Mechanochemical Model to Investigate Tumor Microenvironment Remodeling and Pre-Metastatic Niche Formation.

Hirway S, Nairon K, Skardal A, Weinberg S Cell Mol Bioeng. 2025; 17(6):573-596.

PMID: 39926379 PMC: 11799507. DOI: 10.1007/s12195-024-00831-0.

CircRNA circACTN4 Promotes the Progression of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma by Targeting the miR-424-5p/NCAPG/Wnt Axis.

Shan J, Pu J, Chen X, Zhang Y, Li J, Qin L Clin Exp Med. 2025; 25(1):47.

PMID: 39891781 PMC: 11787268. DOI: 10.1007/s10238-025-01573-7.

Unveiling the link between chronic inflammation and cancer.

Tripathi S, Sharma Y, Kumar D Metabol Open. 2025; 25:100347.

PMID: 39876904 PMC: 11772974. DOI: 10.1016/j.metop.2025.100347.

IL-1β in Neoplastic Disease and the Role of Its Tumor-Derived Form in the Progression and Treatment of Metastatic Prostate Cancer.

Oyende Y, Taus L, Fatatis A Cancers (Basel). 2025; 17(2).

PMID: 39858071 PMC: 11763358. DOI: 10.3390/cancers17020290.

Tumor aggression-defense index-a novel indicator to predicts recurrence and survival in stage II-III colorectal cancer.

Wu T, Fang L, Ruan Y, Shi M, Su D, Ma Y J Transl Med. 2025; 23(1):107.

PMID: 39844178 PMC: 11755833. DOI: 10.1186/s12967-025-06141-x.

References

Pastushenko I, Blanpain C . EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 2018; 29(3):212-226. DOI: 10.1016/j.tcb.2018.12.001. View

Shibue T, Weinberg R . EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017; 14(10):611-629. PMC: 5720366. DOI: 10.1038/nrclinonc.2017.44. View

Dongre A, Rashidian M, Reinhardt F, Bagnato A, Keckesova Z, Ploegh H . Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas. Cancer Res. 2017; 77(15):3982-3989. PMC: 5541771. DOI: 10.1158/0008-5472.CAN-16-3292. View

Campbell K, Casanova J . A common framework for EMT and collective cell migration. Development. 2016; 143(23):4291-4300. DOI: 10.1242/dev.139071. View

Aiello N, Maddipati R, Norgard R, Balli D, Li J, Yuan S . EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. Dev Cell. 2018; 45(6):681-695.e4. PMC: 6014628. DOI: 10.1016/j.devcel.2018.05.027. View

Lamouille S, Xu J, Derynck R . Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014; 15(3):178-96. PMC: 4240281. DOI: 10.1038/nrm3758. View

Steinbichler T, Dudas J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova I . Therapy resistance mediated by cancer stem cells. Semin Cancer Biol. 2018; 53:156-167. DOI: 10.1016/j.semcancer.2018.11.006. View

Sanjabi S, Oh S, Li M . Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection. Cold Spring Harb Perspect Biol. 2017; 9(6). PMC: 5453394. DOI: 10.1101/cshperspect.a022236. View

Guo W, Keckesova Z, Liu Donaher J, Shibue T, Tischler V, Reinhardt F . Slug and Sox9 cooperatively determine the mammary stem cell state. Cell. 2012; 148(5):1015-28. PMC: 3305806. DOI: 10.1016/j.cell.2012.02.008. View

10.

Katsuno Y, Meyer D, Zhang Z, Shokat K, Akhurst R, Miyazono K . Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition. Sci Signal. 2019; 12(570). PMC: 6746178. DOI: 10.1126/scisignal.aau8544. View

11.

Terry S, Savagner P, Ortiz-Cuaran S, Mahjoubi L, Saintigny P, Thiery J . New insights into the role of EMT in tumor immune escape. Mol Oncol. 2017; 11(7):824-846. PMC: 5496499. DOI: 10.1002/1878-0261.12093. View

12.

Pal D, Pertot A, Shirole N, Yao Z, Anaparthy N, Garvin T . TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24- cancer cells. Elife. 2017; 6. PMC: 5345931. DOI: 10.7554/eLife.21615. View

13.

Dongre A, Weinberg R . New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2018; 20(2):69-84. DOI: 10.1038/s41580-018-0080-4. View

14.

Nieto M, Huang R, Jackson R, Thiery J . EMT: 2016. Cell. 2016; 166(1):21-45. DOI: 10.1016/j.cell.2016.06.028. View

15.

Stemmler M, Eccles R, Brabletz S, Brabletz T . Non-redundant functions of EMT transcription factors. Nat Cell Biol. 2019; 21(1):102-112. DOI: 10.1038/s41556-018-0196-y. View